SCVD Faculty

Bridget E Hawkins, PhDBridget E Hawkins, PhD, MBA

Traumatic brain injury (TBI) is a serious problem that affects millions of people in the United States alone. Historically, it was thought of as an event, but research has shown that TBI behaves more like a chronic disease displaying long-lasting effects that can impair cognitive functions like learning and memory for years after the injury. Even “minor” TBIs and concussions obtained from playing sports or from vehicle accidents or falls can have more serious impacts later in life. Many athletes who have suffered multiple concussions have developed early-onset forms of dementia. Troops and civilians returning from combat zones with blast-related injuries are also increasingly more common. Our lab examines the mechanisms of both primary and secondary phases of cell injury following experimental blast-related and non-blast-related TBI. To date, there are no effective treatments to prevent the secondary phase of neuronal injury. Our goals are to evaluate potential therapeutics to prevent the secondary phase of injury and to develop a vaccine that decreases the incidence of developing tau-related dementia following TBI. Dr. Hawkins is part of the Department of Anesthesiology's Charles R. Allen Research Laboratories.

Search PubMed for Dr. Hawkins' publications.